+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Leukemia Drugs Market Research Reports

On average over 40,000 are diagnosed with leukemia each year in the United States. It is also one of the most common cancers in children. Large differences in therapeutic outcomes exist among patient groups such as children and old age sufferers, and according to the form of a disease that has many variants such as Acute (AML) and Chronic (CML) Myelocytic Leukemia, Acute (ALL) and Chronic (CLL) Lymphocytic Leukemia, and Hairy Cell Leukemia (HCL). These variations have led to unmet needs among specific patient groups. The selection of expert and insightful reports in this section enable you explore these market opportunities by providing key industry data such as drug development strategies, international market trends and forecasts and profiles of major players like Novartis, Pfizer and Bristol-Myers Squibb. Show Less Read more

From
BCMA Targeted Therapies, 2017-2030 - Product Thumbnail Image

BCMA Targeted Therapies, 2017-2030

  • Report
  • March 2017
  • 143 Pages
From
From
From
Global Leukemia Partnering 2010 to 2017 - Product Thumbnail Image

Global Leukemia Partnering 2010 to 2017

  • Report
  • March 2017
  • 150 Pages
From
From
Global Leukemia Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Leukemia Therapeutics Market 2016-2020

  • Report
  • September 2016
  • 110 Pages
From
From
Cytarabine (CAS 147-94-4) Market Research Report 2017 - Product Thumbnail Image

Cytarabine (CAS 147-94-4) Market Research Report 2017

  • Report
  • February 2017
  • 70 Pages
From
From
From
Cladribine (CAS 4291-63-8) Market Research Report 2017 - Product Thumbnail Image

Cladribine (CAS 4291-63-8) Market Research Report 2017

  • Report
  • February 2017
  • 70 Pages
From
From
From
From
From
From
From
Loading Indicator
adroll